SHENZHEN, China, Jan. 12, 2026 /PRNewswire/ — Yaber, a globally recognized home tech brand, today announced its expansion into the smart cleaning category. As part of its broader brand development strategy, Yaber continues to evolve its multi-category portfolio under a unified brand architecture that includes its established entertainment line, Yaber Projector, and its newly introduced home… Continue reading Yaber Expands into Smart Cleaning Category with Launch of Two Cordless Vacuum Cleaners
Tag: Financial Results
Yaber Expands into Smart Cleaning Category with Launch of Two Cordless Vacuum Cleaners
SHENZHEN, China, Jan. 11, 2026 /PRNewswire/ — Yaber, a globally recognized home tech brand, today announced its expansion into the smart cleaning category. As part of its broader brand development strategy, Yaber continues to evolve its multi-category portfolio under a unified brand architecture that includes its established entertainment line, Yaber Projector, and its newly introduced home… Continue reading Yaber Expands into Smart Cleaning Category with Launch of Two Cordless Vacuum Cleaners
Rich Sparkle Holdings Closes Acquisition of TikTok Icon Khaby Lame’s Core Company
Exclusive Global Full-Chain Operations Secured—Turning Influence into a Capital-Grade Asset With 360 Million Followers, Annual Live-Commerce Sales Could Reach $4 Billion HONG KONG, Jan. 11, 2026 /PRNewswire/ — Khaby Lame, widely regarded as the world’s defining TikTok creator, built his name on a universal language: silence. No captions needed, no cultural footnotes required—just clarity, humor,… Continue reading Rich Sparkle Holdings Closes Acquisition of TikTok Icon Khaby Lame’s Core Company
REGENXBIO Highlights Key 2026 Catalysts and Announces Positive Long-Term Functional Outcomes in Lead Duchenne Gene Therapy Program
New Phase I/II RGX-202 functional data demonstrates long-term, durable treatment effect at pivotal dose at 18 months Robust patient enrollment in confirmatory trial continues, expect majority of patients to be dosed by planned BLA filing, mid-year Expecting FDA PDUFA decision and multiple pivotal top-line data readouts in 2026 to support potential commercial launches 2026-2028 In-house manufacturing and… Continue reading REGENXBIO Highlights Key 2026 Catalysts and Announces Positive Long-Term Functional Outcomes in Lead Duchenne Gene Therapy Program
Plastic Surgeons Are Using Material From Dead People on New Patients
Illustration by Tag Hartman-Simkins / Futurism. Source: Getty Images Cosmetic surgeons have turned to using a “fat filler” harvested from dead people in order to give patients new breasts, sexier buttocks and other body contouring tweaks, according to reporting by Business Insider — in a practice that not even “Frankenstein” author Mary Shelley could have… Continue reading Plastic Surgeons Are Using Material From Dead People on New Patients
Weekly News Wrap: V2V Mandate, BMW’s 2026 Product Plan, and India’s Record EV Year
The first full week of 2026 set the tone for what is shaping up to be a decisive year for India’s automotive industry, marked by an unusual convergence of policy intent, product aggression and hard data that underscores how quickly the market is evolving. On the regulatory front, road safety moved firmly back into focus,… Continue reading Weekly News Wrap: V2V Mandate, BMW’s 2026 Product Plan, and India’s Record EV Year
Rosen Law Firm Encourages America’s Car-Mart, Inc. Investors to Inquire About Securities Class Action Investigation – CRMT
NEW YORK, Jan. 11, 2026 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of America’s Car-Mart, Inc. (NASDAQ: CRMT) resulting from allegations that America’s Car-Mart may have issued materially misleading business information to the investing public. So What: If you purchased America’s… Continue reading Rosen Law Firm Encourages America’s Car-Mart, Inc. Investors to Inquire About Securities Class Action Investigation – CRMT
Bronstein, Gewirtz & Grossman LLC Urges Varonis Systems, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
NEW YORK, Jan. 11, 2026 /PRNewswire/ — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Varonis Systems, Inc. (NASDAQ: VRNS) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on… Continue reading Bronstein, Gewirtz & Grossman LLC Urges Varonis Systems, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results
PLEASANTON, Calif., Jan. 11, 2026 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced preliminary, unaudited select results for the fourth quarter and full year ended December 31, 2025. Preliminary, Unaudited Select Fourth Quarter 2025 Financial Results Revenue of approximately $166.0 million for the three months ended… Continue reading 10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results
IDEAYA Biosciences Provides a Business Update and Outlines 2026 Corporate Objectives at the 44th Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Jan. 11, 2026 /PRNewswire/ — IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision medicine oncology company, provided a business update including an overview of key corporate objectives for 2026. The company will review these updates during its presentation at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at… Continue reading IDEAYA Biosciences Provides a Business Update and Outlines 2026 Corporate Objectives at the 44th Annual J.P. Morgan Healthcare Conference